Most tissue factory owners are asking the wrong question about dry wipes. They ask whether a nonwoven line is a good purchase.
The better question is what their competitive position looks like in 2029 if they sit out this cycle. Three forces — commoditized tissue margin pressure, regional demand shifts across Asia, the Middle East, and Africa, and peer factories that installed dual-purpose lines five years ago — have aligned into a window closing inside two to three years.
The Tissue Margin Floor Is Moving Up on Non-Integrated Producers
A tissue converter that does not own its pulp is losing ground every quarter. By end of 2024, 45.4 percent of Brazilian tissue capacity had gone vertically integrated, up from 16.3 percent in 2016 — and integrated producers operate at roughly 20 percent lower cost than non-integrated peers. That gap is structural, not cyclical.
Layer the input cost on top. Bleached hardwood kraft pulp ran 14 percent above the prior year in the 2025 cycle, and mid-sized tissue producers in Brazil and Poland posted gross-margin compression upward of 300 basis points in April 2025 disclosures.
For factories in Asia, the Middle East, and Africa the squeeze is sharper — revenue arrives in local currency while pulp and chemicals settle in dollars. Diversifying into higher-value spunlace wipes is no longer a growth ambition. It is margin defense.
Wipe Demand Is Shifting Where Your Next Three Customers Live
The personal-care wipes category is projected to run from USD 14.62 billion in 2025 to USD 18.21 billion in 2030, but the headline number is not the argument — the geographic mix is.
Asia-Pacific sits at USD 1.67 billion in 2025, 32.29 percent of global demand, and is forecast to post the fastest regional growth rate of any wipes market through 2031. China anchors more than 32 percent of that share, India is climbing on public-sector hygiene campaigns, and the Middle East and Africa region is expected to add more than USD 340 million between 2025 and 2030, with the UAE pulling away as the fastest-growing national market.
A tissue factory in Jeddah, Karachi, or Lagos sits on top of the highest-growth wipes geography on the planet. The preference signal reinforces it: cotton and spunlace held 51 percent of the wipes-material market in 2025, and regulatory pressure against synthetic plastic wipes keeps pushing the same direction.
A dry wipe line is how a tissue converter stops exporting commodity tissue into saturated channels and starts supplying the nonwoven substrate their region already demands.
Peer Factories Already Made This Move — Five Years Ago
The uncomfortable truth is that readers debating this investment in 2026 are not early movers. They are closing the window behind themselves.
The Named Precedents
Berry Global commissioned a third Spinlace line at Mooresville, North Carolina in late 2019 — a USD 50 million investment adding 17,000 metric tons of annual spunlace capacity. Papel Aralar brought a wetlaid-spunlace line online at Schwarzenbach/Saale in late 2020, taking the site to 45,000 tons combined across two lines.
Bondex had already invested USD 20 million in a hydroentangled spunlace expansion in South Carolina in 2016. Fibertex Nonwovens in Illinois did not build new — they ramped to 24/7 operation and added needlepunch capacity during the 2020 demand surge. These precedents are five to ten years old.
The Window Is Closing
David Price of Price Hanna Consultants observed that global spunlace production lines ran at full capacity from Q2 2020 through early 2022 on pandemic-driven demand. Allen Huang of KNH has since warned that post-pandemic, spunlace supply may exceed demand.
The reader stands in the gap between those two signals. Factories that move in 2026-2027 ride the last stretch of the capacity-tight window. Factories that wait to 2028-2029 enter a segment where supply and demand have caught up — the ROI math turns on that difference, which is why the companion piece on whether cotton tissue production is profitable in 2026 lays out the unit economics, and why traditional tissue factories are adapting their lines now rather than waiting for perfect visibility.
Dual-Purpose Equipment Is the Hedge, Not a Full Factory Rebuild
The binary framing — build a dedicated dry wipe facility or don’t bother — paralyzes many tissue operators. Fibertex’s shift-expansion playbook is the counter-example: incremental capacity, not greenfield commitment.
A dual-purpose folding line that handles both facial tissue paper and spunlace nonwoven in the 35-120 g/m² range lets an existing factory hedge between segments without betting the building on either one. Our MY-AC Cotton and Facial Tissue Folding Machine was built for this case: one line, two product families, reassignable capacity as regional demand shifts.
The strategic value is not throughput. It is optionality — swinging output toward whichever segment holds margin next quarter without stranding capital. That flexibility is why expanding your product line through customization keeps surfacing with operators.
Four Questions to Answer Before You Greenlight the CAPEX
The investment thesis is not a blanket yes. It is a yes conditional on four questions a prudent capital allocator answers before the purchase order goes out.
- Is your core tissue position defensible for three more years? If you are a non-integrated converter where vertical integration is past 40 percent, diversification is margin defense, not optional.
- Does your regional demand profile support wipes, or are you exporting into oversupplied channels? Asia-Pacific, MEA, and South Asia support the thesis. Mature North American and European markets need a specific customer-contract story.
- Can you install dual-purpose capacity rather than a dedicated line? The hedge beats the bet for most tissue operators already tissue-exposed.
- Have you run the numbers against the window? The ROI math looks different at 2026 entry versus 2028 late-mover economics.
Answer those four honestly, and the conversation moves from “should we?” to “which line configuration and when” — where transition planning and equipment selection earn their keep.
